Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

Early trial results of heart drug suggests Novartis has a winner on its hands

1/04/2014 by

W1siziisijiwmtqvmtavmjgvmtuvndyvndavmtc0l2zpbguixsxbinailcj0ahvtyiisijywmhg0mdbcdtawm2uixv0


Novartis has started the week on a high note, with the pharmaceutical company announcing its plans to terminate a drug trial ahead of schedule. The decision was made on the unanimous recommendation of an independent committee, with the company now seeking approval on the basis of the drug’s positive results thus far.

The drug, LCZ696, was recommended after early results showed that patients trialling it lived longer – and without hospitalization – than patients taking enalapril. Designed to treat heart failure, Novartis is going to present the findings and the case for approval at an upcoming meeting with various global health authorities. Milton Packer, co-Principal investigator of trial, confirmed that the evidence in LCZ696′s favor was indeed strong enough to warrant stopping the trial. “The stopping rule was not on the primary endpoint, it was on cardiovascular death,” he said to Forbes’ Larry Husten. “It was a stopping rule that required a very high level of statistical significance for early termination.”

The news comes in contrast to last week’s response to Serelaxin, another Novartis drug that the U.S. Food and Drug Administration (FDA) turned down for approval. Also intended to treat heart disease, Serelaxin did not present a strong enough case, with minimal evidence to support its claims. Earlier this year, a European advisory committee cast similar judgement, limiting Serelaxin’s future in cardiac medicine.

This article has been extracted from http://www.techtimes.com, please click on this link to read the article in full http://www.techtimes.com/articles/5031/20140331/early-trial-results-of-heart-drug-suggests-novartis-has-a-winner-on-its-hands.htm

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

For more information please visit www.montash.com

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtcvmdmvmdgvmdkvmzkvmtqvmzgxl3dvbwvuigluigj1c2luzxnzlmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Dear 18-year-old me: It’s a woman’s world too

2017-03-08 09:00:00 +0000

With International Women’s Day being all about celebrating the cultural, economic, political and social achievements of women, it highlights the issue of women in technology, which remains a contentious one. Recent research from WISE, which campaigns for gender balance in science, technology and engineering, found that women only make up just 17 per cent of all IT professionals in the UK. Montash Recruitment Consultant Sadiye Booker has shared her exper...

W1siziisijiwmtcvmdivmtuvmtyvntivmjuvnzkwl2n5ymvyigf0dgfja3muanbnil0swyjwiiwidgh1bwiilcizodb4mtawiyjdxq

UK threatened by serious cyber attacks every ...

2017-02-15 16:00:00 +0000

The security of the UK has been threatened by 188 serious cyber attacks in the last three months, a government security chief has said. National Cyber Security Centre (NCSC) Chief Executive Ciaran Martin told The Sunday Times that national security was put at risk by many of these attacks. Martin was speaking ahead of the official opening of the NCSC, which has been set up to protect critical services in the UK from such attacks and improve underlying i...